IRIS
MUTTI, LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 684
EU - Europa 377
AS - Asia 352
SA - Sud America 1
Totale 1.414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 684
IE - Irlanda 330
SG - Singapore 279
CN - Cina 64
IT - Italia 24
DE - Germania 12
HK - Hong Kong 6
FI - Finlandia 5
FR - Francia 3
AM - Armenia 1
BE - Belgio 1
BR - Brasile 1
GB - Regno Unito 1
JP - Giappone 1
LV - Lettonia 1
TR - Turchia 1
Totale 1.414
Salva come PNG Salva come JPEG
Città #
Dublin 330
Santa Clara 294
Singapore 244
Boardman 192
New York 32
Los Angeles 24
Ashburn 17
Dallas 12
L’Aquila 9
Munich 9
Bari 4
Biella 3
Clifton 3
Guangzhou 3
Helsinki 3
Milan 3
Shanghai 3
Washington 3
Albany 2
Fuzhou 2
Lappeenranta 2
Paris 2
Seattle 2
Shenyang 2
Berlin 1
Brussels 1
Cangzhou 1
Cassano Magnago 1
Changsha 1
Chengdu 1
Chifeng 1
Council Bluffs 1
Dalian 1
Forest City 1
Jiangmen 1
Jining 1
London 1
Riga 1
San Francisco 1
Seravezza 1
Shenzhen 1
Shijiazhuang 1
São Paulo 1
Taizhou 1
Tianjin 1
Tokyo 1
Wuxi 1
Xi'an 1
Yerevan 1
Yongzhou 1
Zhengzhou 1
Totale 1.227
Salva come PNG Salva come JPEG
Nome #
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma 29
{CONFIRM} trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 29
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 26
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology 26
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy 25
TNF-α determination in serum and pleural effusion in patients with lung cancer 25
The function and clinical implication of YTHDF1 in the human system development and cancer 25
Abemaciclib for malignant pleural mesothelioma 25
Neuro–Immune Interactions in Severe COVID-19 Infection 24
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma 24
European Respiratory Society Guideline on various aspects of quality in lung cancer care 23
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 22
Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal End Point? 21
The function and clinical implication of circular RNAs in lung cancer 21
Association of SV40 with human tumours 20
P53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification 20
New standard for assessing asbestos exposure and its consequences? 20
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VII th Meeting of the International Mesothelioma Interest Group 20
Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy 20
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations 19
Erionite and asbestos differently cause transformation of human mesothelial cells 19
Chemoprevention of asbestos-linked cancers: A systematic review 19
Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD 19
Genetic susceptibility to malignant mesothelioma and exposure to asbestos: The influence of the familial factor 19
Cancer testis antigens expression in mesothelioma: Role of DNA methylation and bioimmunotherapeutic implications 19
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 19
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma 18
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: A role for autophagy 18
Comparison between plasma and serum osteopontin levels: Usefulness in diagnosis of epithelial malignant pleural mesothelioma 18
What can independent research for mesothelioma achieve to treat this orphan disease? 18
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review 18
SV40 and human brain tumors [2] 17
Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia 17
Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress 17
Preclinical Demonstrations of Synergistic Active Nutrient/Drug (and) Combination as a Potential Treatment for Malignant Pleural Mesothelioma 17
Will antiangiogenic agents be a future for mesothelioma therapy? 17
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo 16
Simian Virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey 16
New agents in the management of advanced mesothelioma 16
Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma 16
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: An open-label, single-arm, phase 2 trial 15
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 15
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications 15
In vivo effect of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil GM-CSF receptors 15
Editorial: Prognostic factors in non-small cell lung cancer 15
Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to Gefitinib 14
Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients 14
When Ron met Tam in mesothelioma: All druggable for one, and one drug for all? 14
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma 14
Recurrent chromosome 6 abnormalities in malignant mesothelioma 13
Taurolidine and oxidative stress: A rationale for local treatment of mesothelioma 13
In arrayed ranks array technology in the study of mesothelioma steven 12
Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution 12
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma 12
Scientific Advances and New Frontiers in Mesothelioma Therapeutics 12
A molecular epidemiology case control study on pleural malignant mesothelioma 11
Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor 11
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism 10
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 10
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma 10
Erratum: Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma (Genes, Chromosomes and Cancer (2000) 29 (173-179)) 9
Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer 8
Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma 8
Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis 8
Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies? 8
Anti-CTLA-4 therapy for malignant mesothelioma 8
Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo 8
Current treatment options and biology of peritoneal mesothelioma: Meeting summary of the first NIH peritoneal mesothelioma conference 8
Identification of overexpressed genes in malignant pleural mesothelioma 8
Targeting hypoxic response for cancer therapy 7
Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts 7
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) 7
Epigallocatechin-3-gallate induces mesothelioma cell death via H2O2-dependent T-type Ca2+ channel opening 7
SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure 7
SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: A molecular epidemiologic case-control study 7
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma 7
Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo 7
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma 7
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma 7
Expression of glycoprotein 90K in human malignant pleural mesothelioma: Correlation with patient survival 7
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma 6
Evaluation of a series of serum mesothelin in patients with pleural Malignant Mesothelioma 6
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases 6
Simian virus 40 and malignant mesothelioma (Review) 6
BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment 6
High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma 6
Gamma/delta T-lymphocytes in advanced pulmonary asbestosis 6
Sustained expression of steroid receptor coactivator SRC-2/TIF-2 is associated with better prognosis in malignant pleural mesothelioma 6
Serum osteopontin levels in previously asbestos-exposed workers 6
Study of the combined role of asbestos and SV40 in the pathogenesis of malignant mesothelioma 6
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma 6
Anti-SV40 antibodies as infection markers for assessing additional risk factors in workers previously exposed to asbestos 6
Serum Mesothelin dosages in follow-up of previously exposed workers 6
The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor 6
Establishment of four new mesothelioma cell lines: Characterization by ultrastructural and immunophenotypic analysis 6
Surgery for malignant pleural mesothelioma: An international guidelines review 6
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 6
Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas 6
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 6
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe 6
Totale 1.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023395 0 0 0 0 0 0 0 53 327 0 4 11
2023/2024354 7 13 18 55 19 141 0 7 3 26 24 41
2024/2025811 176 28 153 30 215 209 0 0 0 0 0 0
Totale 1.560